The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global RNA Next-Generation Sequencing Market Research Report 2025
Synopsis
RNA next-generation sequencing refer to the use of next-generation sequencing to reveal the presence and quantity of RNA in a biological sample at a given moment.
The global RNA Next-Generation Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for RNA Next-Generation Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNA Next-Generation Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for RNA Next-Generation Sequencing in Research Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of RNA Next-Generation Sequencing include Roche, Illumina, Thermo Fisher Scientific, Beckman Coulter, Abbott Molecular, Pacific Biosciences, Oxford Nanopore Technologies, Eurofins Scientific and Macrogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNA Next-Generation Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Next-Generation Sequencing.
Report Scope
The RNA Next-Generation Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNA Next-Generation Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Next-Generation Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Illumina
Thermo Fisher Scientific
Beckman Coulter
Abbott Molecular
Pacific Biosciences
Oxford Nanopore Technologies
Eurofins Scientific
Macrogen
GENEWIZ
BGI
Berry Genomics
QIAGEN
Segment by Type
Enrichment Approaches
Amplicon-Based Approaches
Segment by Application
Research Institutes
Hospitals and Clinics
Biotechnology Company
Diagnostic Lab
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Next-Generation Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
RNA next-generation sequencing refer to the use of next-generation sequencing to reveal the presence and quantity of RNA in a biological sample at a given moment.
The global RNA Next-Generation Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for RNA Next-Generation Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNA Next-Generation Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for RNA Next-Generation Sequencing in Research Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of RNA Next-Generation Sequencing include Roche, Illumina, Thermo Fisher Scientific, Beckman Coulter, Abbott Molecular, Pacific Biosciences, Oxford Nanopore Technologies, Eurofins Scientific and Macrogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNA Next-Generation Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Next-Generation Sequencing.
Report Scope
The RNA Next-Generation Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNA Next-Generation Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Next-Generation Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Illumina
Thermo Fisher Scientific
Beckman Coulter
Abbott Molecular
Pacific Biosciences
Oxford Nanopore Technologies
Eurofins Scientific
Macrogen
GENEWIZ
BGI
Berry Genomics
QIAGEN
Segment by Type
Enrichment Approaches
Amplicon-Based Approaches
Segment by Application
Research Institutes
Hospitals and Clinics
Biotechnology Company
Diagnostic Lab
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Next-Generation Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Next-Generation Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Enrichment Approaches
1.2.3 Amplicon-Based Approaches
1.3 Market by Application
1.3.1 Global RNA Next-Generation Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Institutes
1.3.3 Hospitals and Clinics
1.3.4 Biotechnology Company
1.3.5 Diagnostic Lab
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Next-Generation Sequencing Market Perspective (2019-2030)
2.2 RNA Next-Generation Sequencing Growth Trends by Region
2.2.1 Global RNA Next-Generation Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 RNA Next-Generation Sequencing Historic Market Size by Region (2019-2024)
2.2.3 RNA Next-Generation Sequencing Forecasted Market Size by Region (2025-2030)
2.3 RNA Next-Generation Sequencing Market Dynamics
2.3.1 RNA Next-Generation Sequencing Industry Trends
2.3.2 RNA Next-Generation Sequencing Market Drivers
2.3.3 RNA Next-Generation Sequencing Market Challenges
2.3.4 RNA Next-Generation Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Next-Generation Sequencing Players by Revenue
3.1.1 Global Top RNA Next-Generation Sequencing Players by Revenue (2019-2024)
3.1.2 Global RNA Next-Generation Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global RNA Next-Generation Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Next-Generation Sequencing Revenue
3.4 Global RNA Next-Generation Sequencing Market Concentration Ratio
3.4.1 Global RNA Next-Generation Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Next-Generation Sequencing Revenue in 2023
3.5 RNA Next-Generation Sequencing Key Players Head office and Area Served
3.6 Key Players RNA Next-Generation Sequencing Product Solution and Service
3.7 Date of Enter into RNA Next-Generation Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Next-Generation Sequencing Breakdown Data by Type
4.1 Global RNA Next-Generation Sequencing Historic Market Size by Type (2019-2024)
4.2 Global RNA Next-Generation Sequencing Forecasted Market Size by Type (2025-2030)
5 RNA Next-Generation Sequencing Breakdown Data by Application
5.1 Global RNA Next-Generation Sequencing Historic Market Size by Application (2019-2024)
5.2 Global RNA Next-Generation Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America RNA Next-Generation Sequencing Market Size (2019-2030)
6.2 North America RNA Next-Generation Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RNA Next-Generation Sequencing Market Size by Country (2019-2024)
6.4 North America RNA Next-Generation Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Next-Generation Sequencing Market Size (2019-2030)
7.2 Europe RNA Next-Generation Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RNA Next-Generation Sequencing Market Size by Country (2019-2024)
7.4 Europe RNA Next-Generation Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Next-Generation Sequencing Market Size (2019-2030)
8.2 Asia-Pacific RNA Next-Generation Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RNA Next-Generation Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific RNA Next-Generation Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Next-Generation Sequencing Market Size (2019-2030)
9.2 Latin America RNA Next-Generation Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RNA Next-Generation Sequencing Market Size by Country (2019-2024)
9.4 Latin America RNA Next-Generation Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Next-Generation Sequencing Market Size (2019-2030)
10.2 Middle East & Africa RNA Next-Generation Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RNA Next-Generation Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa RNA Next-Generation Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche RNA Next-Generation Sequencing Introduction
11.1.4 Roche Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina RNA Next-Generation Sequencing Introduction
11.2.4 Illumina Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.2.5 Illumina Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific RNA Next-Generation Sequencing Introduction
11.3.4 Thermo Fisher Scientific Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter RNA Next-Generation Sequencing Introduction
11.4.4 Beckman Coulter Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 Abbott Molecular
11.5.1 Abbott Molecular Company Detail
11.5.2 Abbott Molecular Business Overview
11.5.3 Abbott Molecular RNA Next-Generation Sequencing Introduction
11.5.4 Abbott Molecular Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.5.5 Abbott Molecular Recent Development
11.6 Pacific Biosciences
11.6.1 Pacific Biosciences Company Detail
11.6.2 Pacific Biosciences Business Overview
11.6.3 Pacific Biosciences RNA Next-Generation Sequencing Introduction
11.6.4 Pacific Biosciences Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.6.5 Pacific Biosciences Recent Development
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Detail
11.7.2 Oxford Nanopore Technologies Business Overview
11.7.3 Oxford Nanopore Technologies RNA Next-Generation Sequencing Introduction
11.7.4 Oxford Nanopore Technologies Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.7.5 Oxford Nanopore Technologies Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific RNA Next-Generation Sequencing Introduction
11.8.4 Eurofins Scientific Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.8.5 Eurofins Scientific Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Detail
11.9.2 Macrogen Business Overview
11.9.3 Macrogen RNA Next-Generation Sequencing Introduction
11.9.4 Macrogen Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.9.5 Macrogen Recent Development
11.10 GENEWIZ
11.10.1 GENEWIZ Company Detail
11.10.2 GENEWIZ Business Overview
11.10.3 GENEWIZ RNA Next-Generation Sequencing Introduction
11.10.4 GENEWIZ Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.10.5 GENEWIZ Recent Development
11.11 BGI
11.11.1 BGI Company Detail
11.11.2 BGI Business Overview
11.11.3 BGI RNA Next-Generation Sequencing Introduction
11.11.4 BGI Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.11.5 BGI Recent Development
11.12 Berry Genomics
11.12.1 Berry Genomics Company Detail
11.12.2 Berry Genomics Business Overview
11.12.3 Berry Genomics RNA Next-Generation Sequencing Introduction
11.12.4 Berry Genomics Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.12.5 Berry Genomics Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Detail
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN RNA Next-Generation Sequencing Introduction
11.13.4 QIAGEN Revenue in RNA Next-Generation Sequencing Business (2019-2024)
11.13.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global RNA Next-Generation Sequencing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Enrichment Approaches
Table 3. Key Players of Amplicon-Based Approaches
Table 4. Global RNA Next-Generation Sequencing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global RNA Next-Generation Sequencing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global RNA Next-Generation Sequencing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global RNA Next-Generation Sequencing Market Share by Region (2019-2024)
Table 8. Global RNA Next-Generation Sequencing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global RNA Next-Generation Sequencing Market Share by Region (2025-2030)
Table 10. RNA Next-Generation Sequencing Market Trends
Table 11. RNA Next-Generation Sequencing Market Drivers
Table 12. RNA Next-Generation Sequencing Market Challenges
Table 13. RNA Next-Generation Sequencing Market Restraints
Table 14. Global RNA Next-Generation Sequencing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global RNA Next-Generation Sequencing Market Share by Players (2019-2024)
Table 16. Global Top RNA Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Next-Generation Sequencing as of 2023)
Table 17. Ranking of Global Top RNA Next-Generation Sequencing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by RNA Next-Generation Sequencing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players RNA Next-Generation Sequencing Product Solution and Service
Table 21. Date of Enter into RNA Next-Generation Sequencing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global RNA Next-Generation Sequencing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global RNA Next-Generation Sequencing Revenue Market Share by Type (2019-2024)
Table 25. Global RNA Next-Generation Sequencing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global RNA Next-Generation Sequencing Revenue Market Share by Type (2025-2030)
Table 27. Global RNA Next-Generation Sequencing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global RNA Next-Generation Sequencing Revenue Market Share by Application (2019-2024)
Table 29. Global RNA Next-Generation Sequencing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global RNA Next-Generation Sequencing Revenue Market Share by Application (2025-2030)
Table 31. North America RNA Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America RNA Next-Generation Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America RNA Next-Generation Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe RNA Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe RNA Next-Generation Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe RNA Next-Generation Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific RNA Next-Generation Sequencing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific RNA Next-Generation Sequencing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific RNA Next-Generation Sequencing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America RNA Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America RNA Next-Generation Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America RNA Next-Generation Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa RNA Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa RNA Next-Generation Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa RNA Next-Generation Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche RNA Next-Generation Sequencing Product
Table 49. Roche Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Illumina Company Detail
Table 52. Illumina Business Overview
Table 53. Illumina RNA Next-Generation Sequencing Product
Table 54. Illumina Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 55. Illumina Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific RNA Next-Generation Sequencing Product
Table 59. Thermo Fisher Scientific Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Beckman Coulter Company Detail
Table 62. Beckman Coulter Business Overview
Table 63. Beckman Coulter RNA Next-Generation Sequencing Product
Table 64. Beckman Coulter Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 65. Beckman Coulter Recent Development
Table 66. Abbott Molecular Company Detail
Table 67. Abbott Molecular Business Overview
Table 68. Abbott Molecular RNA Next-Generation Sequencing Product
Table 69. Abbott Molecular Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 70. Abbott Molecular Recent Development
Table 71. Pacific Biosciences Company Detail
Table 72. Pacific Biosciences Business Overview
Table 73. Pacific Biosciences RNA Next-Generation Sequencing Product
Table 74. Pacific Biosciences Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 75. Pacific Biosciences Recent Development
Table 76. Oxford Nanopore Technologies Company Detail
Table 77. Oxford Nanopore Technologies Business Overview
Table 78. Oxford Nanopore Technologies RNA Next-Generation Sequencing Product
Table 79. Oxford Nanopore Technologies Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 80. Oxford Nanopore Technologies Recent Development
Table 81. Eurofins Scientific Company Detail
Table 82. Eurofins Scientific Business Overview
Table 83. Eurofins Scientific RNA Next-Generation Sequencing Product
Table 84. Eurofins Scientific Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 85. Eurofins Scientific Recent Development
Table 86. Macrogen Company Detail
Table 87. Macrogen Business Overview
Table 88. Macrogen RNA Next-Generation Sequencing Product
Table 89. Macrogen Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 90. Macrogen Recent Development
Table 91. GENEWIZ Company Detail
Table 92. GENEWIZ Business Overview
Table 93. GENEWIZ RNA Next-Generation Sequencing Product
Table 94. GENEWIZ Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 95. GENEWIZ Recent Development
Table 96. BGI Company Detail
Table 97. BGI Business Overview
Table 98. BGI RNA Next-Generation Sequencing Product
Table 99. BGI Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 100. BGI Recent Development
Table 101. Berry Genomics Company Detail
Table 102. Berry Genomics Business Overview
Table 103. Berry Genomics RNA Next-Generation Sequencing Product
Table 104. Berry Genomics Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 105. Berry Genomics Recent Development
Table 106. QIAGEN Company Detail
Table 107. QIAGEN Business Overview
Table 108. QIAGEN RNA Next-Generation Sequencing Product
Table 109. QIAGEN Revenue in RNA Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 110. QIAGEN Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA Next-Generation Sequencing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global RNA Next-Generation Sequencing Market Share by Type: 2023 VS 2030
Figure 3. Enrichment Approaches Features
Figure 4. Amplicon-Based Approaches Features
Figure 5. Global RNA Next-Generation Sequencing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global RNA Next-Generation Sequencing Market Share by Application: 2023 VS 2030
Figure 7. Research Institutes Case Studies
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Biotechnology Company Case Studies
Figure 10. Diagnostic Lab Case Studies
Figure 11. RNA Next-Generation Sequencing Report Years Considered
Figure 12. Global RNA Next-Generation Sequencing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global RNA Next-Generation Sequencing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global RNA Next-Generation Sequencing Market Share by Region: 2023 VS 2030
Figure 15. Global RNA Next-Generation Sequencing Market Share by Players in 2023
Figure 16. Global Top RNA Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Next-Generation Sequencing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by RNA Next-Generation Sequencing Revenue in 2023
Figure 18. North America RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America RNA Next-Generation Sequencing Market Share by Country (2019-2030)
Figure 20. United States RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe RNA Next-Generation Sequencing Market Share by Country (2019-2030)
Figure 24. Germany RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific RNA Next-Generation Sequencing Market Share by Region (2019-2030)
Figure 32. China RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America RNA Next-Generation Sequencing Market Share by Country (2019-2030)
Figure 40. Mexico RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa RNA Next-Generation Sequencing Market Share by Country (2019-2030)
Figure 44. Turkey RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia RNA Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 47. Illumina Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 49. Beckman Coulter Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 50. Abbott Molecular Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 51. Pacific Biosciences Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 52. Oxford Nanopore Technologies Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 53. Eurofins Scientific Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 54. Macrogen Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 55. GENEWIZ Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 56. BGI Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 57. Berry Genomics Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 58. QIAGEN Revenue Growth Rate in RNA Next-Generation Sequencing Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
